Invention Grant
- Patent Title: Treatment of autoimmune disease in a patient receiving additionally a beta-blocker
-
Application No.: US17209940Application Date: 2021-03-23
-
Publication No.: US11944602B2Publication Date: 2024-04-02
- Inventor: Eric Legangneux , Alexandros Sagkriotis , Pierre Jordaan , Florine Polus , Alan John Camm , Shibadas Biswal , Parasar Pal , Uday Kiran Veldandi , Atul Keshav Pawar , Vassilios Aslanis , Kasra Shakeri-Nejad
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Adil R. Zhugralin
- Priority: IN 9DEL2015 2015.02.26
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K9/20 ; A61K31/138 ; A61K45/06 ; A61P37/00
Abstract:
The present invention relates to methods of treating autoimmune diseases with siponimod in patients receiving additionally a beta-blocker.
Public/Granted literature
- US20220008385A1 TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER Public/Granted day:2022-01-13
Information query
